Gliclazide

格列齐特

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameGliclazide
Drug Alias NameGliclazidum盐酸格列齐特Gliclazida甲磺双环脲克里克那隆 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSulfonylurea receptor agonists
TargetsSulfonylurea receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryVietnamMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShanxi Wanglong Pharmaceutical Group Co Ltd
Inactive CompaniesHanoi Medical UniversityGuangzhou Pui'S Pharmaceutical Factory Ltd
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BB09
Related LinksWikipediaDrugBankKEGG